JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
47,906
23,559
44,848
45,161
Short Term Investments
141,968
212,093
104,410
0
Total Cash
189,874
235,652
149,258
45,161
Net Receivables
-
-
-
-
Inventory
-
-
-
-
Other Current Assets
-
43
510
5
Total Current Assets
192,209
255,597
151,787
45,711
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
21,545
20,325
12,038
7,946
Accumulated Depreciation
-8,005
-4,174
-4,797
-2,853
Net property, plant and equipment
13,540
16,151
7,241
5,093
Equity and other investments
5,990
22,199
108,116
0
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
2,713
2,713
4,168
2,171
Total non-current assets
22,243
41,063
119,525
7,264
Total Assets
214,452
296,660
271,312
52,975
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
-
Accounts Payable
3,272
2,849
3,511
2,618
Taxes payable
-
-
-
-
Accrued liabilities
2,889
4,771
3,204
1,595
Deferred revenues
55,157
51,142
80,544
0
Other Current Liabilities
104
45
43
45
Total Current Liabilities
65,546
62,551
90,673
6,722
Non-current liabilities
Long Term Debt
-
-
-
-
Deferred taxes liabilities
-
-
-
-
Deferred revenues
42,715
65,018
107,260
0
Other long-term liabilities
-
27
56
89
Total non-current liabilities
44,777
67,000
108,768
1,397
Total Liabilities
110,323
129,551
199,441
8,119
Stockholders' Equity
Common Stock
33
32
140,961
103,618
Retained Earnings
-163,907
-89,615
-73,172
-59,469
Accumulated other comprehensive income
-78
-409
-433
0
Total stockholders' equity
104,129
167,109
71,871
44,856
Total liabilities and stockholders' equity
214,452
296,660
271,312
52,975